Patent ID: 7262165

Claim:
An aqueous pharmaceutical composition comprising: an oligopeptide of formula I cyclo-(n-Arg-nGly-nAsp-nD-nE) (I) in which D and E each, independently of one another, denote Gly, Ala, β-Ala, Asn, Asp, Asp(OR), Arg, Cha, Cys, Gln, Glu, His, Ile, Leu, Lys, Lys(Ac), Lys(AcNH 2 ), Lys(AcSH), Met, Nal, NIe, Orn, Phe, 4-Hal-Phe, homoPhe, Phg, Pro, Pya, Ser, Thr, Tia, Tic, Trp, Tyr or Val; R denotes alkyl having 1-18 C atoms; Hal denotes F, Cl Br or I; Ac denotes alkanoyl having 1-10 C atoms, aroyl having 7-11 C atoms or aralkanoyl having 8-12 C atoms; and n denotes H, R, benzyl or aralkyl radical having 7-18 C atoms on the alpha-amino function of the corresponding amino acid, with the proviso that at least one amino acid has a substituent n, where n denotes R, and where, if the amino acids are optically active, both the D and L forms are included, and physiologically acceptable salts thereof; and an etherified β-cyclodextrin having a water solubility of greater than 1.8 mg/ml in water.